New Results
Non-classical estrogen signaling inhibits melanoma and improves response to PD-1 blockade
View ORCID ProfileChristopher A. Natale, Jinyang Li, Junqian Zhang, Ankit Dahal, Ben Z. Stanger, View ORCID ProfileTodd W. Ridky
doi: https://doi.org/10.1101/146498
Christopher A. Natale
1Perelman School of Medicine, Department of Dermatology, University of Pennsylvania, Philadelphia, PA 19104, USA
Jinyang Li
1Perelman School of Medicine, Department of Dermatology, University of Pennsylvania, Philadelphia, PA 19104, USA
Junqian Zhang
1Perelman School of Medicine, Department of Dermatology, University of Pennsylvania, Philadelphia, PA 19104, USA
Ankit Dahal
1Perelman School of Medicine, Department of Dermatology, University of Pennsylvania, Philadelphia, PA 19104, USA
Ben Z. Stanger
2Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.
Todd W. Ridky
1Perelman School of Medicine, Department of Dermatology, University of Pennsylvania, Philadelphia, PA 19104, USA
Article usage
Posted June 06, 2017.
Non-classical estrogen signaling inhibits melanoma and improves response to PD-1 blockade
Christopher A. Natale, Jinyang Li, Junqian Zhang, Ankit Dahal, Ben Z. Stanger, Todd W. Ridky
bioRxiv 146498; doi: https://doi.org/10.1101/146498
Subject Area
Subject Areas
- Biochemistry (11718)
- Bioengineering (8724)
- Bioinformatics (29132)
- Biophysics (14936)
- Cancer Biology (12051)
- Cell Biology (17360)
- Clinical Trials (138)
- Developmental Biology (9406)
- Ecology (14146)
- Epidemiology (2067)
- Evolutionary Biology (18269)
- Genetics (12223)
- Genomics (16768)
- Immunology (11844)
- Microbiology (28016)
- Molecular Biology (11560)
- Neuroscience (60822)
- Paleontology (450)
- Pathology (1864)
- Pharmacology and Toxicology (3231)
- Physiology (4940)
- Plant Biology (10401)
- Synthetic Biology (2878)
- Systems Biology (7333)
- Zoology (1642)